Serial Number | 90905974 |
Word Mark | VANDRIA |
Filing Date | Friday, August 27, 2021 |
Status | 733 - FOURTH EXTENSION - GRANTED |
Status Date | Friday, October 25, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, October 18, 2022 |
Goods and Services | Pharmaceuticals for the treatment of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, muscular diseases, disorders, and conditions, bone diseases, disorders, and conditions, neurological and neurodegenerative diseases, disorders, and conditions, metabolic diseases, disorders, and conditions, renal diseases, disorders, and conditions, ophthalmological diseases, disorders, and conditions, oncological diseases, disorders, and conditions, immune system and autoimmune diseases, disorders, and conditions, endocrine system diseases, disorders, and conditions, pulmonary and respiratory diseases, disorders, and conditions, hepatic diseases, disorders, and conditions, gastrointestinal diseases, disorders, and conditions, and diseases, disorders, and conditions related to aging |
Goods and Services | Research and development of pharmaceuticals in the fields of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, muscular diseases, disorders, and conditions, bone diseases, disorders, and conditions, neurological and neurodegenerative diseases, disorders, and conditions, metabolic diseases, disorders, and conditions, renal diseases, disorders, and conditions, ophthalmological diseases, disorders, and conditions, oncological diseases, disorders, and conditions, immune system and autoimmune diseases, disorders, and conditions, endocrine system diseases, disorders, and conditions, pulmonary and respiratory diseases, disorders, and conditions, hepatic diseases, disorders, and conditions, gastrointestinal diseases, disorders, and conditions, and diseases, disorders, and conditions related to aging |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, September 29, 2021 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, September 29, 2021 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | VANDRIA SA |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | LAUSANNE 1015 CH |
Party Name | VANDRIA SA |
Party Type | 11 - New Owner Before Publication |
Legal Entity Type | 03 - Corporation |
Address | LAUSANNE 1015 CH |
Party Name | Amazentis SA |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Ecublens 1024 CH |
Event Date | Event Description |
Wednesday, January 26, 2022 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Tuesday, August 31, 2021 | NEW APPLICATION ENTERED |
Wednesday, September 29, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, June 6, 2022 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Thursday, June 2, 2022 | ASSIGNED TO EXAMINER |
Monday, June 6, 2022 | SUSPENSION LETTER WRITTEN |
Monday, June 6, 2022 | LETTER OF SUSPENSION E-MAILED |
Friday, September 2, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, August 3, 2022 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Thursday, September 1, 2022 | ASSIGNED TO LIE |
Friday, September 2, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, September 9, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, September 28, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, October 18, 2022 | PUBLISHED FOR OPPOSITION |
Tuesday, October 18, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, December 13, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Thursday, March 23, 2023 | SOU TEAS EXTENSION RECEIVED |
Thursday, March 23, 2023 | SOU EXTENSION 1 FILED |
Thursday, March 23, 2023 | SOU EXTENSION 1 GRANTED |
Saturday, March 25, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, September 18, 2023 | SOU TEAS EXTENSION RECEIVED |
Monday, September 18, 2023 | SOU EXTENSION 2 FILED |
Monday, September 18, 2023 | SOU EXTENSION 2 GRANTED |
Wednesday, September 20, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, April 8, 2024 | SOU EXTENSION 3 FILED |
Monday, April 8, 2024 | SOU TEAS EXTENSION RECEIVED |
Monday, April 8, 2024 | SOU EXTENSION 3 GRANTED |
Friday, October 25, 2024 | SOU TEAS EXTENSION RECEIVED |
Friday, October 25, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Friday, October 25, 2024 | SOU EXTENSION 4 GRANTED |
Friday, October 25, 2024 | SOU EXTENSION 4 FILED |
Tuesday, April 9, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |